Bristol-Myers Squibb Co. (BMY) Misses Q3 EPS by 1c; Sees EPS at High End

October 24, 2012 7:33 AM

Bristol-Myers Squibb Co. (NYSE: BMY) reported Q3 EPS of $0.41, $0.01 worse than the analyst estimate of $0.42 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found